Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Dhawan BN |
Effect of drugs on LSD-25 induced pyrexia in rabbits. |
Arch.internat.de pha... |
1959 |
Seiden LS, Fischman MW, S... |
Long-term methamphetamine induced changes in brain catecholamines in t... |
Drug Alcohol Depend |
1976 |
Martin P, Consroe P |
Cannabinoid Induced Behavioral Convulsions in Rabbits |
Science |
1976 |
Pryor GT, Husain S, Mitom... |
Acute and Subacute Interactions Between delta-9-Tetrahydrocannabinol a... |
Ann.N.Y.Acad.Sci. |
1976 |
Frischknecht HR, Waser PG |
Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Am... |
Gen.Pharmacol. |
1978 |
Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
Riedlinger JE |
The scheduling of MDMA: a pharmacist's perspective |
J Psychoactive Drugs |
1985 |
Seymour RB, Wesson DR, Sm... |
Editor's Introduction |
J Psychoactive Drugs |
1986 |
Beardsley PM, Balster RL,... |
Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... |
Drug Alcohol Depend |
1986 |
Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
Kamien JB, Johanson CE, S... |
The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylene... |
Drug Alcohol Depend |
1986 |
Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
Boja JW, Schechter MD |
Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE... |
Pharmacol Biochem Be... |
1987 |
Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
Schechter MD |
MDMA as a discriminative stimulus: isomeric comparisons |
Pharmacol Biochem Be... |
1987 |
Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
Thompson DM, Winsauer PJ,... |
Effects of phencyclidine, ketamine and MDMA on complex operant behavio... |
Pharmacol Biochem Be... |
1987 |
Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
Nencini P, Woolverton WL,... |
Enhancement of morphine-induced analgesia after repeated injections of... |
Brain Res |
1988 |
O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
Gazzara RA, Takeda H, Cho... |
Inhibition of dopamine release by methylenedioxymethamphetamine is med... |
Eur J Pharmacol |
1989 |
Gold LH, Koob GF |
MDMA produces stimulant-like conditioned locomotor activity |
Psychopharmacology (... |
1989 |
Gollamudi R, Ali SF, Lipe... |
Influence of inducers and inhibitors on the metabolism in vitro and ne... |
Neurotoxicology |
1989 |
Insel TR, Battaglia G, Jo... |
3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... |
J Pharmacol Exp Ther |
1989 |
Johnson M, Hanson GR, Gib... |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... |
Eur J Pharmacol |
1989 |
Kleven MS, Woolverton WL,... |
Evidence that both intragastric and subcutaneous administration of met... |
Brain Res |
1989 |
Li AA, Marek GJ, Vosmer G... |
Long-term central 5-HT depletions resulting from repeated administrati... |
Pharmacol Biochem Be... |
1989 |
Mansbach RS, Braff DL, Ge... |
Prepulse inhibition of the acoustic startle response is disrupted by N... |
Eur J Pharmacol |
1989 |
Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
Stone DM, Johnson M, Hans... |
Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... |
Eur J Pharmacol |
1989 |
Bilsky EJ, Hui YZ, Hubbel... |
Methylenedioxymethamphetamine's capacity to establish place preference... |
Pharmacol Biochem Be... |
1990 |
Cho AK, Hiramatsu M, Dist... |
Stereochemical differences in the metabolism of 3,4-methylenedioxymeth... |
Drug Metab Dispos |
1990 |
De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
Hashimoto K, Goromaru T |
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... |
Fundam Clin Pharmaco... |
1990 |
Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
Nash JF |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in th... |
Life Sci |
1990 |
Nash JF, Meltzer HY, Gude... |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... |
J Neurochem |
1990 |
Ricaurte GA, Finnegan KT,... |
Aminergic metabolites in cerebrospinal fluid of humans previously expo... |
Ann N Y Acad Sci |
1990 |
Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
Schmidt CJ, Black CK, Abb... |
Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... |
Eur J Pharmacol |
1990 |
Schmidt CJ, Black CK, Abb... |
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... |
Brain Res |
1990 |
Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
Schmidt CJ, Taylor VL |
Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by ... |
Eur J Pharmacol |
1990 |
Winslow JT, Insel TR |
Serotonergic modulation of rat pup ultrasonic vocal development: studi... |
J Pharmacol Exp Ther |
1990 |
Zacny JP, Virus RM, Woolv... |
Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1990 |
Greer GR,Tolbert R |
The Therapeutic Use of MDMA |
Ecstasy: The clinica... |
1990 |
Chiang CN, Hawks RL |
Research Findings on Smoking of Abused Substances |
NIDA Research Monogr... |
1990 |
Paris JM, Cunningham KA |
Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... |
NIDA Res Monogr |
1991 |
Callaway CW, Johnson MP, ... |
Amphetamine derivatives induce locomotor hyperactivity by acting as in... |
Psychopharmacology (... |
1991 |
Champney TH, Matthews RT |
Pineal serotonin is resistant to depletion by serotonergic neurotoxins... |
J Pineal Res |
1991 |
Dornan WA, Katz JL, Ricau... |
The effects of repeated administration of MDMA on the expression of se... |
Pharmacol Biochem Be... |
1991 |
Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
Nash JF, Arora RC, Schrei... |
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... |
Biochem Pharmacol |
1991 |
Nash JF, Brodkin J |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dop... |
J Pharmacol Exp Ther |
1991 |
Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
Sharkey J, McBean DE, Kel... |
Alterations in hippocampal function following repeated exposure to the... |
Psychopharmacology (... |
1991 |
Yeh SY, Hsu FL |
The neurochemical and stimulatory effects of putative metabolites of 3... |
Pharmacol Biochem Be... |
1991 |
Hanson GR, Bunker CF, Joh... |
Response of monoaminergic and neuropeptide systems to 4-methylaminorex... |
Eur J Pharmacol |
1992 |
Gouzoulis E, Steiger A, E... |
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... |
Biol Psychiatry |
1992 |
Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
Elayan I, Gibb JW, Hanson... |
Long-term alteration in the central monoaminergic systems of the rat b... |
Eur J Pharmacol |
1992 |
Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
Hashimoto K, Maeda H, Gor... |
Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... |
Brain Res |
1992 |
Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
Johnson M, Mitros K, Ston... |
Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... |
J Pharmacol Exp Ther |
1992 |
Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
Liester MB, Grob CS, Brav... |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use |
J Nerv Ment Dis |
1992 |
Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
Paris JM, Cunningham KA |
Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... |
Brain Res Bull |
1992 |
Rezvani AH, Garges PL, Mi... |
Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of... |
Pharmacol Biochem Be... |
1992 |
Scheffel U, Lever JR, Sta... |
Repeated administration of MDMA causes transient down-regulation of se... |
Neuropharmacology |
1992 |
Schmidt CJ, Black CK, Tay... |
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... |
Eur J Pharmacol |
1992 |
Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
Ali SF, Newport GD, Scall... |
Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produc... |
Neurotoxicol Teratol |
1993 |
Brodkin J, Malyala A, Nas... |
Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1993 |
Colado MI, Murray TK, Gre... |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... |
Br J Pharmacol |
1993 |
Hashimoto K |
Effects of benzylpiperazine derivatives on the acute effects of 3,4-me... |
Neurosci Lett |
1993 |
Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
Krebs KM, Geyer MA |
Behavioral characterization of alpha-ethyltryptamine, a tryptamine der... |
Psychopharmacology (... |
1993 |
Tirzite D, Tirzitis G, Vi... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
Gouzoulis E, von Bardeleb... |
Neuroendocrine and cardiovascular effects of MDE in healthy volunteers |
Neuropsychopharmacol... |
1993 |